| Literature DB >> 33498262 |
Anamaria Jurcau1,2.
Abstract
Dementia, and especially Alzheimer's disease (AD), puts significant burden on global healthcare expenditure through its increasing prevalence. Research has convincingly demonstrated the implication of oxidative stress in the pathogenesis of dementia as well as of the conditions which increase the risk of developing dementia. However, drugs which target single pathways have so far failed in providing significant neuroprotection. Natural antioxidants, due to their effects in multiple pathways through which oxidative stress leads to neurodegeneration and triggers neuroinflammation, could prove valuable weapons in our fight against dementia. Although efficient in vitro and in animal models of AD, natural antioxidants in human trials have many drawbacks related to the limited bioavailability, unknown optimal dose, or proper timing of the treatment. Nonetheless, trials evaluating several of these natural compounds are ongoing, as are attempts to modify these compounds to achieve improved bioavailability.Entities:
Keywords: Alzheimer’s disease; cognitive decline; natural antioxidants; oxidative stress; polyphenols
Mesh:
Substances:
Year: 2021 PMID: 33498262 PMCID: PMC7909256 DOI: 10.3390/nu13020282
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717